Home/AviadoBio/Graeme Fielder, PhD
GF

Graeme Fielder, PhD

Chief Operating Officer

AviadoBio

AviadoBio Pipeline

DrugIndicationPhase
AVB-101Frontotemporal Dementia with GRN mutations (FTD-GRN)Phase 1/2
Program(s) for Retinitis PigmentosaRetinal DystrophiesPre-clinical
Program(s) for ALSAmyotrophic Lateral SclerosisPre-clinical
Program(s) for TauopathiesAlzheimer's Disease and other TauopathiesPre-clinical